Collagen IV Diseases: A Focus on the Glomerular Basement Membrane in Alport Syndrome

Overview

Journal Matrix Biol

Publisher Elsevier

Specialties Biochemistry
Molecular Biology

Date 2016 Aug 31

PMID 27576055

Citations 62

Authors

Dominic Cosgrove

Shiguang Liu

Affiliations

Soon will be listed here.

Abstract

Alport syndrome is the result of mutations in any of three type IV collagen genes, COL4A3, COL4A4, or COL4A5. Because the three collagen chains form heterotrimers, there is an absence of all three proteins in the basement membranes where they are expressed. In the glomerulus, the mature glomerular basement membrane type IV collagen network, normally comprised of two separate networks, α3(IV)/α4(IV)/α5(IV) and α1(IV)/α2(IV), is comprised entirely of collagen α1(IV)/α2. This review addresses the current state of our knowledge regarding the consequence of this change in basement membrane composition, including both the direct, via collagen receptor binding, and indirect, regarding influences on glomerular biomechanics. The state of our current understanding regarding mechanisms of glomerular disease initiation and progression will be examined, as will the current state of the art regarding emergent therapeutic approaches to slow or arrest glomerular disease in Alport patients.

Citing Articles

Whole-genome sequencing revealed a novel structural variant in causing autosomal dominant Alport syndrome: A case report.

Delage C, Andreani M, Boukrout N, Sabaouni N, Perrais M, Lefebvre B Heliyon. 2024; 10(24):e40802.

PMID: 39735618 PMC: 11681849. DOI: 10.1016/j.heliyon.2024.e40802.

Personalized Antifibrotic Therapy in CKD Progression.

Delrue C, Eisenga M, Delanghe J, Speeckaert M J Pers Med. 2024; 14(12).

PMID: 39728054 PMC: 11678888. DOI: 10.3390/jpm14121141.

Characterization of the Ocular Phenotype in a Col4a3 Knockout Mouse Model of Alport Syndrome.

Belamkar A, Luo Q, Mahajan N, Abhyankar S, Jones B, Sodhi R Invest Ophthalmol Vis Sci. 2024; 65(14):29.

PMID: 39680378 PMC: 11654772. DOI: 10.1167/iovs.65.14.29.

Natural History of Auditory Function in Patients with Alport Syndrome: A Case Series Study.

Nam J, Jung H, Won D, Gee H, Choi J, Jung J J Clin Med. 2024; 13(22).

PMID: 39597783 PMC: 11594709. DOI: 10.3390/jcm13226639.

A human stem cell-derived model reveals pathologic extracellular matrix remodeling in diabetic podocyte injury.

Roye Y, Miller C, Kalejaiye T, Musah S Matrix Biol Plus. 2024; 24:100164.

PMID: 39582511 PMC: 11585791. DOI: 10.1016/j.mbplus.2024.100164.

References

Crockett D, Pont-Kingdon G, Gedge F, Sumner K, Seamons R, Lyon E . The Alport syndrome COL4A5 variant database. Hum Mutat. 2010; 31(8):E1652-7. DOI: 10.1002/humu.21312. View

Ruster C, Wolf G . Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol. 2006; 17(11):2985-91. DOI: 10.1681/ASN.2006040356. View

Delimont D, Dufek B, Meehan D, Zallocchi M, Gratton M, Phillips G . Laminin α2-mediated focal adhesion kinase activation triggers Alport glomerular pathogenesis. PLoS One. 2014; 9(6):e99083. PMC: 4051676. DOI: 10.1371/journal.pone.0099083. View

Kuhn K . Basement membrane (type IV) collagen. Matrix Biol. 1995; 14(6):439-45. DOI: 10.1016/0945-053x(95)90001-2. View

Heikkila P, Parpala T, Lukkarinen O, Weber M, Tryggvason K . Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system - first steps towards gene therapy of Alport syndrome. Gene Ther. 1996; 3(1):21-7. View

Rao V, Meehan D, Delimont D, Nakajima M, Wada T, Gratton M . Role for macrophage metalloelastase in glomerular basement membrane damage associated with alport syndrome. Am J Pathol. 2006; 169(1):32-46. PMC: 1698763. DOI: 10.2353/ajpath.2006.050896. View

Kashtan C, Kim Y, Lees G, Thorner P, Virtanen I, Miner J . Abnormal glomerular basement membrane laminins in murine, canine, and human Alport syndrome: aberrant laminin alpha2 deposition is species independent. J Am Soc Nephrol. 2001; 12(2):252-260. DOI: 10.1681/ASN.V122252. View

Gross O, Girgert R, Beirowski B, Kretzler M, Kang H, Kruegel J . Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease. Matrix Biol. 2010; 29(5):346-56. DOI: 10.1016/j.matbio.2010.03.002. View

Kalluri R, Shield C, Todd P, Hudson B, Neilson E . Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J Clin Invest. 1997; 99(10):2470-8. PMC: 508088. DOI: 10.1172/JCI119431. View

10.

Hahm K, Lukashev M, Luo Y, Yang W, Dolinski B, Weinreb P . Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse. Am J Pathol. 2007; 170(1):110-25. PMC: 1762706. DOI: 10.2353/ajpath.2007.060158. View

11.

Gross O, Beirowski B, Koepke M, Kuck J, Reiner M, Addicks K . Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome. Kidney Int. 2003; 63(2):438-46. DOI: 10.1046/j.1523-1755.2003.00779.x. View

12.

Rodgers K, Rao V, Meehan D, Fager N, Gotwals P, Ryan S . Monocytes may promote myofibroblast accumulation and apoptosis in Alport renal fibrosis. Kidney Int. 2003; 63(4):1338-55. DOI: 10.1046/j.1523-1755.2003.00871.x. View

13.

Borza D, Bondar O, Ninomiya Y, Sado Y, Naito I, Todd P . The NC1 domain of collagen IV encodes a novel network composed of the alpha 1, alpha 2, alpha 5, and alpha 6 chains in smooth muscle basement membranes. J Biol Chem. 2001; 276(30):28532-40. DOI: 10.1074/jbc.M103690200. View

14.

Kim M, Piaia A, Shenoy N, Kagan D, Gapp B, Kueng B . Progression of Alport Kidney Disease in Col4a3 Knock Out Mice Is Independent of Sex or Macrophage Depletion by Clodronate Treatment. PLoS One. 2015; 10(11):e0141231. PMC: 4640715. DOI: 10.1371/journal.pone.0141231. View

15.

Barocas V, Dorfman K, Segal Y . A model of strain-dependent glomerular basement membrane maintenance and its potential ramifications in health and disease. J Biomech Eng. 2012; 134(8):081006. DOI: 10.1115/1.4007098. View

16.

Sachs N, Claessen N, Aten J, Kreft M, Teske G, Koeman A . Blood pressure influences end-stage renal disease of Cd151 knockout mice. J Clin Invest. 2011; 122(1):348-58. PMC: 3248294. DOI: 10.1172/JCI58878. View

17.

Krugmann S, Jordens I, Gevaert K, Driessens M, Vandekerckhove J, Hall A . Cdc42 induces filopodia by promoting the formation of an IRSp53:Mena complex. Curr Biol. 2001; 11(21):1645-55. DOI: 10.1016/s0960-9822(01)00506-1. View

18.

Lin X, Suh J, Go G, Miner J . Feasibility of repairing glomerular basement membrane defects in Alport syndrome. J Am Soc Nephrol. 2013; 25(4):687-92. PMC: 3968506. DOI: 10.1681/ASN.2013070798. View

19.

Timpl R, Brown J . Supramolecular assembly of basement membranes. Bioessays. 1996; 18(2):123-32. DOI: 10.1002/bies.950180208. View

20.

Sayers R, Kalluri R, RODGERS K, Shield C, Meehan D, Cosgrove D . Role for transforming growth factor-beta1 in alport renal disease progression. Kidney Int. 1999; 56(5):1662-73. DOI: 10.1046/j.1523-1755.1999.00744.x. View